TREATMENT PATTERNS AND OUTCOMES IN THE FRENCH COHORT OF PATIENTS WITH UNRESECTABLE STAGE III OR STAGE IV MELANOMA (MELODY STUDY): A RETROSPECTIVE LONGITUDINAL SURVEY

被引：0
|
作者：
Bedane, C. [1 ]
Leccia, M. T. [2 ]
Sassolas, B. [3 ]
Mansard, S. [4 ]
Guillot, B. [5 ]
Mortier, L. [6 ]
Robert, C. [7 ]
Saiag, P. [8 ]
Truchetet, F. [9 ]
Oukessou, A. [10 ]
Bregman, B. [10 ]
Lebbe, C. [11 ]
机构：
[1] Hop Dupuytren, Limoges, France
[2] Hop Michallon, La Tronche, France
[3] Hop Morvan, Brest, France
[4] Hop Hotel Dieu, Clermont Ferrand, France
[5] Hop St Eloi, Montpellier, France
[6] Hop Claude Huriez, Lille, France
[7] Inst Gustave Roussy, Villejuif, France
[8] Hop Ambroise Pare, Boulogne, France
[9] Hop Beauregard, Thionville, France
[10] Bristol Myers Squibb Co, Rueil Malmaison, France
[11] Hop St Louis, Paris, France
来源：
VALUE IN HEALTH | 2010年 / 13卷 / 07期
关键词：
D O I：
10.1016/S1098-3015(11)72007-1
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A273 / A273
页数：1
相关论文
共 50 条
  • [31] TREATMENT PATTERNS AMONG PATIENTS WITH ADVANCED MELANOMA: A RETROSPECTIVE LONGITUDINAL STUDY
    O'Leary, B.
    Colman, S.
    Ruth, A.
    Kotapati, S.
    Cook, G.
    VALUE IN HEALTH, 2010, 13 (07) : A517 - A517
  • [32] Adjuvant immunotherapy in older patients with stage III and resected stage IV melanoma: Toxicity and recurrence-free survival outcomes from the Dutch melanoma treatment registry
    Ozkan, A.
    Kapiteijn, E.
    van den Bos, F.
    Aarts, M. J. B.
    van den Berkmortel, F. W. P. J.
    Blank, C. U.
    Bloem, M.
    Blokx, W. A. M.
    Boers-Sonderen, M. J.
    Bonenkamp, J. J.
    van den Eertwegh, A. J. M.
    de Groot, J. W. B.
    Haanen, J. B.
    Holtslag, C. E.
    Hospers, G. A. P.
    Piersma, D.
    van Rijn, R. S.
    Boer, A. M. Stevense-den
    Suijkerbuijk, K. P. M.
    van der Veldt, A. A. M.
    Vreugdenhil, G.
    Wouters, M. W. J. M.
    Portielje, J. E. A.
    de Glas, N. A.
    EUROPEAN JOURNAL OF CANCER, 2024, 212
  • [33] Impact of Primary Tumor Resection on Mortality in Patients with Stage IV Colorectal Cancer with Unresectable Metastases: A Multicenter Retrospective Cohort Study
    Kawamura, Hidetaka
    Ogawa, Yusuke
    Yamazaki, Hajime
    Honda, Michitaka
    Kono, Koji
    Konno, Shinichi
    Fukuhara, Shunichi
    Yamamoto, Yosuke
    WORLD JOURNAL OF SURGERY, 2021, 45 (10) : 3230 - 3239
  • [34] Sequencing of Immunotherapy and Outcomes in Operable Clinical Stage III Melanoma: A National Cohort Study
    Dheer, Anushka
    Tortorello, Gabriella N.
    Shafique, Neha
    Farooq, Mohammad S.
    Mitchell, Tara C.
    Xu, Xiaowei
    Miura, John T.
    Karakousis, Giorgos C.
    JOURNAL OF SURGICAL ONCOLOGY, 2024,
  • [35] Impact of Primary Tumor Resection on Mortality in Patients with Stage IV Colorectal Cancer with Unresectable Metastases: A Multicenter Retrospective Cohort Study
    Hidetaka Kawamura
    Yusuke Ogawa
    Hajime Yamazaki
    Michitaka Honda
    Koji Kono
    Shinichi Konno
    Shunichi Fukuhara
    Yosuke Yamamoto
    World Journal of Surgery, 2021, 45 : 3230 - 3239
  • [36] Retrospective cohort study of unresectable stage III non-small-cell lung cancer in Canada
    Seung, S. J.
    Hurry, M.
    Walton, R. N.
    Evans, W. K.
    CURRENT ONCOLOGY, 2020, 27 (04) : E354 - E360
  • [37] Phase II study of ipilimumab (IPI) in children and adolescents with unresectable stage III or IV malignant melanoma (MEL).
    Pappo, Alberto S.
    Bergeron, Christophe
    Gore, Lia
    Sender, Leonard S.
    Dunkel, Ira J.
    Herzog, Cynthia E.
    Brochez, Lieve
    Cruz, Ofelia
    Nysom, Karsten
    Berghorn, Elmer
    Simsek, Burcin
    Shen, Jun
    Geoerger, Birgit
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [38] Demographics, Clinical Characteristics and Treatment Sequencing in Stage III Unresectable NSCLC Patients: A Cancerlinq Cohort
    Klein, A.
    Herr, I.
    Maclachlan, S.
    Potter, D.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S687 - S687
  • [39] Treatment patterns and effectiveness outcomes in patients with stage IV, renal cell carcinoma
    Copher, Ronda
    Lin, Junji
    Chatterjee, Debanjana
    Joshi, Prashant Ramesh
    Fisher, Maxine D.
    Walker, Mark S.
    Kerr, Jiandong
    Zakharia, Yousef
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [40] A phase II study of YM155 administered as 168 hour continuous infusion in stage IV and unresectable stage III melanoma.
    Alexandrescu, Doru T.
    Gonzales, Rene
    Lewis, Karl
    Samlowski, Wolfram
    Cranmer, Lee
    Catlett, Joseph
    Kirkwood, John
    Whitman, Eric
    Lawson, David
    Bartels, P.
    Drake, Terry
    Keating, Anne
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3385S - 3385S
12345